Sorin wins Japanese OK for heart valve

December 4, 2012 by MassDevice staff

Sorin Group says the Japanese Pharmaceuticals and Medical Devices Agency approved its Mitroflow aortic pericardial heart valve.

Sorin Group

Sorin Group (BIT:SRN) said it plans to launch its Mitroflow heart valve in Japan now that a regulatory body there has approved its use.

The Japanese Pharmaceuticals and Medical Devices Agency OK'd the aortic pericardial heart valve, which is surgically implanted to replace the aortic valve in patients with aortic stenosis, according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp